SELLAS Life Sciences (SLS) Return on Capital Employed (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,377.00 |
| Dec 31, 2025 | 2,601.00 |
| Sep 30, 2025 | 2,356.00 |
| Jun 30, 2025 | 3,917.00 |
| Mar 31, 2025 | 9,660.00 |
| Dec 31, 2024 | 8,718.00 |
| Sep 30, 2024 | 12,883.00 |
| Jun 30, 2024 | 362,325.00 |
| Mar 31, 2024 | -464,871.00 |
| Dec 31, 2023 | 303,526.00 |
| Sep 30, 2023 | -210,541.00 |
| Jun 30, 2023 | 2,911.00 |
| Mar 31, 2023 | 14,355.00 |
| Dec 31, 2022 | -26,064.00 |
| Sep 30, 2022 | 3,375.00 |
| Jun 30, 2022 | 164.00 |
| Mar 31, 2022 | -20,873.00 |
| Dec 31, 2021 | -4,295.00 |
| Sep 30, 2021 | -974.00 |
| Jun 30, 2021 | 7.00 |
| Mar 31, 2021 | 4,455.00 |
| Dec 31, 2020 | 8,895.00 |
| Sep 30, 2020 | 1,263.00 |
| Jun 30, 2020 | -1,973.00 |
| Dec 31, 2017 | -11,446.00 |
| Sep 30, 2017 | 387.00 |
| Jun 30, 2017 | 54,965.00 |
| Mar 31, 2017 | -52,746.00 |
| Dec 31, 2016 | 5,783.00 |
| Sep 30, 2016 | 4,590.00 |
| Jun 30, 2016 | -4,393.00 |
| Mar 31, 2016 | 2,806.00 |
| Dec 31, 2015 | -6,929.00 |
| Sep 30, 2015 | -882.00 |
| Jun 30, 2015 | 1,725.00 |
| Mar 31, 2015 | 1,658.00 |
| Dec 31, 2014 | 280.00 |
| Sep 30, 2014 | -1,504.00 |
| Jun 30, 2014 | -2,525.00 |
| Mar 31, 2014 | 5,168.00 |
| Dec 31, 2013 | -3,749.00 |
| Sep 30, 2013 | 397.00 |
| Jun 30, 2013 | -1,652.00 |
| Mar 31, 2013 | 6,306.00 |